Integrated Genomic Analysis of Chromosomal Alterations and Mutations in B-Cell Acute Lymphoblastic Leukemia Reveals Distinct Genetic Profiles at Relapse

• Published in: Diagnostics (Basel) Vol. 10; no. 7; p. 455
• Main Authors: Forero-Castro, Maribel, Montaño, Adrián, Robledo, Cristina, García de Coca, Alfonso, Fuster, José Luis, de las Heras, Natalia, Queizán, José Antonio, Hernández-Sánchez, María, Corchete-Sánchez, Luis A., Martín-Izquierdo, Marta, Ribera, Jordi, Ribera, José-María, Benito, Rocío, Hernández-Rivas, Jesús M.
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 04.07.2020; MDPI
• Subjects: acute lymphoblastic leukemia (ALL); Adults; array comparative genomic hybridization (aCGH); Bone marrow; Cancer; Deoxyribonucleic acid; DNA; Genes; Genetic testing; IKZF1; Leukemia; Life sciences; multiplex ligation-dependent probe amplification (MLPA); Mutation; next-generation sequencing (NGS); Patients; relapse; United States > US
• ISSN: 2075-4418; 2075-4418
• DOI: 10.3390/diagnostics10070455

The clonal basis of relapse in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is complex and not fully understood. Next-generation sequencing (NGS), array comparative genomic hybridization (aCGH), and multiplex ligation-dependent probe amplification (MLPA) were carried out in matched diagnosis–relapse samples from 13 BCP-ALL patients to identify patterns of genetic evolution that could account for the phenotypic changes associated with disease relapse. The integrative genomic analysis of aCGH, MLPA and NGS revealed that 100% of the BCP-ALL patients showed at least one genetic alteration at diagnosis and relapse. In addition, there was a significant increase in the frequency of chromosomal lesions at the time of relapse (p = 0.019). MLPA and aCGH techniques showed that IKZF1 was the most frequently deleted gene. TP53 was the most frequently mutated gene at relapse. Two TP53 mutations were detected only at relapse, whereas the three others showed an increase in their mutational burden at relapse. Clonal evolution patterns were heterogeneous, involving the acquisition, loss and maintenance of lesions at relapse. Therefore, this study provides additional evidence that BCP-ALL is a genetically dynamic disease with distinct genetic profiles at diagnosis and relapse. Integrative NGS, aCGH and MLPA analysis enables better molecular characterization of the genetic profile in BCP-ALL patients during the evolution from diagnosis to relapse.